Olavide Neuron STX S.L. (ONESTX)
Contact information
Olavide Neuron STX S.L.
Ángel Cebolla - CEO
Calzada Romana, 40
Camas - 41900
Sevilla
+34 657 816 904
Areas of activities
- Biodrugs
- Central nervous system
Commissions
The company aims to provide innovative therapies that address the fundamental causes of neurodegeneration, particularly those related to aging and protein aggregation
Products and services
The first objective is to develop ONTX-01 (also known as STX64 or Irosustat), a first-in-class oral compound designed to stabilize endogenous sulfated neurosteroids by inhibiting steroid sulfatase (STS). This novel mechanism seeks to restore synaptic plasticity, reduce neuroinflammation, promote brain rejuvenation,
Areas of interest for future collaborations
Investment partners sought to enter clinical phases and further development.
Codevelopment of biomarkers for monitoring the progression of neurodegeneration and aging.
Codevelopment of combined anti-aging therapies. Drugs addressing the biology of aging.